Report : North America Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Wide-Neck Bifurcation Aneurysms and Narrow-Neck Bifurcation Aneurysms) and End user (Hospitals, Clinics, and Ambulatory Surgical Centers)
The wide-neck bifurcation aneurysms segment by application is estimated to lead the market growth during the forecast period.
According to a new market research study of “North America Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application, End User and Country.” The North America coil assisted flow diverters market is expected to reach US$ 214.24 million in 2028 from US$ 126.01 million in 2021; it is estimated to grow at a CAGR of 7.9% from 2021-2028. The report highlights trends prevailing in the North America coil assisted flow diverters market and the factors driving market along with those that act as hindrances.
Key factors that are driving growth of the market are rising incidence of intracranial aneurysms and growing incidence of hypertension, smoking, alcoholism, and obesity fuel the growth of the market. However, high cost of neurosurgical devices is expected to restrict the market growth during the forecast period. Coil assisted flow diverters are stent-like devices that are used to for the embolization of intracranial aneurysms. Thus, increasing incidence of intracranial aneurysms is propelling the demand for coil assisted flow diverters. As per the Brain Aneurysm Foundation, Statistics and Facts report, in the US, around 6.5 million people that is 1 in 50 people have an unruptured brain aneurysm. It has further reported that, every year, around 30,000 people in the US suffer a brain aneurysm rupture and a brain aneurysm rupture takes place every 18 minutes. Thus, increasing prevalence of intracranial aneurysms is creating high demand for coil assisted flow diverters. Also, hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for coil assisted flow diverters. In addition to this, the growing geriatric population, the rise in associated neurological disorders and technological advancements in coil assisted flow diverters across North America are likely to create growth opportunities for the market.
The COVID-19 situation in the North America region has stabilized as compared to the initial phase of the pandemic. Over the past couple of years, the treatment processes for the COVID-19 have been developed. Thus, there have been remarkable reductions of the load over the healthcare system and other healthcare services such as treatments, surgeries, and others. Moreover, the vaccination process has gained speed, and more and more people are getting their vaccinations. Thus, the COVID-19 has a relatively less impact on the coil assisted flow diverters market.
The North America coil assisted flow diverters market, by application, is segmented into wide-neck bifurcation aneurysms, and narrow bifurcation aneurysms. Based on end user, the North America coil assisted flow diverters market is segmented into hospitals, clinics, and ambulatory surgical centers. Geographically, the North America coil assisted flow diverters market can be sub-segmented into U.S, Canada and Mexico.
Balt USA LLC, MicroPort Scientific Corporation, Stryker Corporation, Penumbra, Inc, Medtronic, Acandis GmbH, MicroVention Inc, Johnson and Johnson Services, Inc., Lepu Medical Technology Co. Ltd., and Cerus Endovascular are among the leading companies operating in the North America coil assisted flow diverters market.
Contact Person: Sameer Joshi
Email Id: email@example.com